StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
HEALTHYLIFE.BO$6.29-2.43%
Fair $6.29+0.0%

HEALTHYLIFE.BO

Healthy Life Agritec Limited

Consumer Defensive / Farm ProductsBSE

$6.29

-0.16 (-2.43%)

Fairly Valued+0.0%Fair Value $6.29Fund rank 25/100 · Data gapFallback financials|
SA 51/C
F-Score: 3/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 19%

FCF escenarios

weak_data · normalized FCF $-89.6M · quality 50.0/100

Data gap 25/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 11/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

51/100

C

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · HEALTHYLIFE.BOLocal privado en este navegador · Healthy Life Agritec Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$312M

P/E

12.8x

↓

EV/EBITDA

6.6x

↓

ROE

9.5%

↑

Gross Margin

4.5%

↓

Debt/Equity

0.22

↓
52-Week Range$6
$5$74

TradingView lightweight chart

HEALTHYLIFE.BO price, volumen y niveles de valoración

Último $6.430Periodo -92.1%
Fair value: $6.290

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+71.7%

FCF CAGR

—

FCF margin

-5.2%

FCF / Net income

-2.75x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.72B · net income $32.6M · FCF $-89.6M

2022-FY → 2025-FY

Gross margin

4.5%-1.9% pts

Operating margin

2.8%-0.6% pts

Net margin

1.9%-0.5% pts

FCF margin

-5.2%+23.5% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$1.72B$1.72B$1.33B$1.08B$339.6M
Net Income$32.6M$32.6M$25.1M$15.1M$8.1M
EBITDA$47.9M$47.9M$36.1M$23.1M$11.6M
EPS0.850.850.720.510.23
Gross Margin4.5%4.5%4.5%5.0%6.4%
Operating Margin2.8%2.8%2.6%2.7%3.4%
Net Margin1.9%1.9%1.9%1.4%2.4%
Balance Sheet
Debt/Equity0.220.220.090.050.08
Cash Flow
Free Cash Flow$-89.6M$-89.6M$-11.6M$-130.7M$-97.4M
Returns
ROE9.5%9.5%9.3%6.2%7.5%
Valuation
P/E12.8412.84———
EV/EBITDA6.586.58———
P/B0.700.70———
Growth & Yield
Revenue Growth29.3%29.3%23.3%217.5%—
EPS Growth18.2%18.2%40.6%118.9%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-13.0%

fácil

EPS terminal req.

$0.56

Spread vs growth

31.2%

5Y implied EPS CAGR

-4.4%

fácil

EPS terminal req.

$0.68

Spread vs growth

22.6%

10Y implied EPS CAGR

2.5%

fácil

EPS terminal req.

$1.09

Spread vs growth

15.7%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -89.9%

Total return

-89.9%

Start / end P/E

88.5x → 7.6x

EPS bridge

0.72 → 0.85

Residual

-16.6%

EPS growth+18.2%
Multiple rerating-91.4%
Dividend+0.0%
Residual / FX / buybacks / cross-term-16.6%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.